Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NIH conference. New insights into common variable immunodeficiency

M C Sneller1, W Strober, E Eisenstein

  • 1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

Annals of Internal Medicine
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agreement and disagreement in pediatric functional neurological symptom disorders: Comparing patient reported outcome measures (PROMs) and clinician assessments.

Computational and structural biotechnology journal·2024
Same author

Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry.

Clinical rheumatology·2022
Same author

Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells.

Science immunology·2020
Same author

Chemical chaperones reverse early suppression of regulatory circuits during unfolded protein response in B cells from common variable immunodeficiency patients.

Clinical and experimental immunology·2019
Same author

Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

Journal of viral hepatitis·2016
Same author

Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

The New England journal of medicine·2016
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Common variable immunodeficiency (CVI) is a complex immune disorder causing low antibody levels and frequent infections. This review covers CVI

Area of Science:

  • Immunology
  • Clinical Medicine

Background:

  • Common variable immunodeficiency (CVI) is a heterogeneous syndrome.
  • Characterized by hypogammaglobulinemia, recurrent bacterial infections, and immune abnormalities.
  • Associated with increased risks of autoimmune disease and malignancy.

Purpose of the Study:

  • To review the pathogenesis of CVI.
  • To outline clinical manifestations and diagnostic approaches.
  • To discuss current treatment strategies for CVI.

Main Methods:

  • Literature review of CVI pathogenesis, clinical features, diagnosis, and treatment.
  • Synthesis of information from relevant scientific publications.

Main Results:

  • CVI presents with a broad spectrum of associated diseases.

Related Experiment Videos

  • Patients require multidisciplinary specialist care.
  • Understanding pathogenesis is key to managing CVI.

    • Conclusions:

    • CVI management requires a comprehensive approach.
    • Early diagnosis and treatment are crucial for patient outcomes.
    • Further research into CVI pathogenesis may improve therapies.